Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo

Cancer Science

Volumn 104, Issue 7, 2013, Pages 889-895

  Yokoyama, Yuhki ^a   Hieda, Miki ^a   Nishioka, Yu ^a   Matsumoto, Ayaka ^a   Higashi, Satomi ^a   Kimura, Hiroshi ^a   Yamamoto, Hirofumi ^a   Mori, Masaki ^a   Matsuura, Shuji ^a   Matsuura, Nariaki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE H3 LYSINE 9 METHYLTRANSFERASE; METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SIZE; CANCER SURVIVAL; CARCINOGENESIS; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; HISTONE METHYLATION; HISTONE TRIMETHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ANIMALS; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; EPIGENESIS, GENETIC; FEMALE; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYSINE; MALE; METHYLATION; METHYLTRANSFERASES; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; REPRESSOR PROTEINS; UP-REGULATION;

EID: 84880706636     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12166     Document Type: Article

References (37)

1. Füllgrabe J, Kavanagh E, Joseph B. Histone onco-modifications. Oncogene 2011; 30: 3391-403.
2. Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 2012; 13: 343-57.
3. Fraga MF, Ballestar E, Villar-Garea A et al. Loss of acetylation at Lys16 and tri-methylation at Lys20 ofhistone H4 is a common hallmark of human cancer. Nat Genet 2005; 37: 391-400.
4. Behbahani TE, Kahl P, von der Gathen J et al. Alterations of global histone H4K20 methylation during prostate carcinogenesis. BMC Urol 2012; 12: 5.
5. Seligson DB, Horvath S, Shi T et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435: 1262-6.
6. Song JS, Kim YS, Kim DK, Park SI, Jang SJ. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients. Pathol Int 2012; 62: 182-90.
7. Park YS, Jin MY, Kim YJ, Yook JH, Kim BS, Jang SJ. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol 2008; 15: 1968-76.
8. Nguyen CT, Weisenberger DJ, Velicescu M et al. H3K9: Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. Cancer Res 2002; 62: 6456-61.
9. Elsheikh SE, Green AR, Rakha EA et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 2009; 69: 3802-9.
10. Nakazawa T, Kondo T, Ma D et al. Global histone modification of histone H3 in colorectal cancer and its precursor lesions. Hum Pathol 2012; 43: 834-42.
11. Chi P, Allis CD, Wang GG. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 2010; 10: 457-69.
12. Albert M, Helin K. Histone methyltransferases in cancer. Semin Cell Dev Biol 2010; 21: 209-20.
13. Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006; 5: 37-50.
14. Kelly TK, De Carvalho DD, Jones PA. Epigenetic modifications as therapeutic targets. Nat Biotechnol 2010; 28: 1069-78.
15. Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5: 769-84.
16. Wagner T, Jung M. New lysine methyltransferase drug targets in cancer. Nat Biotechnol 2012; 30: 622-3.
17. Yamaguchi H, Wyckoff J, Condeelis J. Cell migration in tumors. Curr Opin Cell Biol 2005; 17: 559-64.
18. Gerlitz G, Bustin M. The role of chromatin structure in cell migration. Trends Cell Biol 2011; 21: 6-11.
19. Gerlitz G, Livnat I, Ziv C, Yarden O, Bustin M, Reiner O. Migration cues induce chromatin alterations. Traffic 2007; 8: 1521-9.
20. Gerlitz G, Bustin M. Efficient cell migration requires global chromatin condensation. J Cell Sci 2010; 123: 2207-17.
21. Tanaka H, Nishioka Y, Yokoyama Y et al. Nuclear envelope-localized EGF family protein amphiregulin activates breast cancer cell migration in an EGF-like domain independent manner. Biochem Biophys Res Commun 2012; 420: 721-6.
22. Schotta G, Lachner M, Sarma K et al. A silencing pathway to induce H3-K9 and H4-K20 tri-methylation at constitutive heterochromatin. Genes Dev 2004; 18: 1251-62.
23. Kimura H, Hayashi-Takanaka Y, Goto Y et al. The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct Funct 2008; 33: 61-73.
24. Hieda M, Isokane M, Koizumi M et al. Membrane-anchored growth factor HB-EGF, on the cell surface targeted to the inner nuclear membrane. J Cell Biol 2008; 180: 763-9.
25. Rea S, Eisenhaber F, O'Carroll D et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406: 593-9.
26. Greiner D, Bonaldi T, Eskeland R, Roemer E, Imhof A. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol 2005; 3: 143-5.
27. Grewal SIS, Jia S. Heterochromatin revisited. Nat Rev Genet 2007; 8: 35-46.
28. Miller SA, Mohn SE, Weinmann AS. JMJD3 and UTX play a demethylase- independent role in chromatin remodeling to regulate T-box family member-dependent gene expression. Mol Cell 2010; 40: 594-605.
29. Chen MW, Hua KT, Kao HJ et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res 2010; 70: 7830-40.
30. Crisp M, Liu Q, Roux K et al. Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Biol 2005; 172: 41-53.
31. Méjat A, Misteli T. LINC complexes in health and disease. Nucleus 2010; 1: 40-52.
32. Malone CJ, Misner L, Le Bot N et al. The C. elegans hook protein, ZYG-12, mediates the essential attachment between the centrosome and nucleus. Cell 2003; 115: 825-36.
33. Kondo Y, Shen L, Ahmed S et al. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS ONE 2008; 3: e2037. doi:10.1371/journal.pone.0002037.
34. Watanabe H, Soejima K, Yasuda H et al. Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 2008; 8: 15.
35. Kang MY, Lee BB, Kim YH et al. Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. Int J Cancer 2007; 121: 2192-7.
36. Friedl P, Alexander S. Cancer invasion and metastasis: plasticity and reciprocity. Cell 2011; 174: 992-1009.
37. Friedl M, Locker J, Sahai E, Jeffrey E. Segall Classifying collective cancer cell invasion. Nat Cell Biol 2012; 14: 777-83.